Center of Laboratory Medicine
Aarau, 5001, Switzerland
NCT Number: NCT01436383
The trial investigates changes in metabolism during high altitude expedition up to 6865m. A mass-spectrometry based platform is used to detect different oxidative stress related metabolites. Symptoms of acute mountain sickness are evaluated and correlated with laboratory parameters.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Aarau, 5001, Switzerland
Background
Altitude related illness, which include acute mountain sickness (AMS), high altitude pulmonary edema (HAPE) and high altitude cerebral edema (HACE), is common in subjects exposed to high altitude during professional or leisure time activities. There are independent risk factors such as: individual susceptibility and rate of ascent. HAPE is a potentially life-threatening complication of high altitude stay, mostly occuring within the first 2-5 days of exposure. Although there is a controversial discussion, excessive hypoxic pulmonary vasoconstriction is thought to be the main trigger for developing HAPE. Beside the controversial discussion if hypobaric hypoxia leads to oxidative stress it is not known whether oxidative stress contributes to AMS or HAPE.
Objective
The investigators hypothesize that reactive oxygen species are generated during high altitude stay and contribute to the development of acute mountain sickness. Furthermore they would like to describe other changes in metabolic pathways possibly contributing to vessel tone dysregulation.
Methods
36 healthy volunteers will examined during an high altitude medical research expedition to Mount Muztagh ata (7549m) in Western China. Acute mountain sickness scores and clinical parameters will be assessed. Metabolomics analysis of more than 390 parameters, using a mass spectrometry-based targeted metabolomic platform, is used to detect systemic oxidative stress and functional impairment of enzymes that require oxidation-sensitive co-factors. Furthermore routine laboratory test will be done, for example CRP, creatinine and interleukines
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hypoxic exposure
Time frame: during ascent, expected to be approximately 19-23 days
Time frame: during ascent, expected to be approximately 19-23 days
Time frame: during ascent, expected to be approximately 19-23 days
Time frame: during ascent, expected to be approximately 19-23 days
Insel Gruppe AG, University Hospital Bern
Other
Oxidative Stress in Hypobaric Hypoxia and Influence on Vessel-tone Modifying Mediators
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06446427
Altitude Sickness, Behavior
Bern, Switzerland
View Trial DetailsNCT05073406
Cognitive Performance, Emergency Medicine
Bolzano, BZ, Italy
View Trial DetailsNCT04138446
Cognitive Deterioration, Emergency Medicine
Bolzano, BZ, Italy
View Trial DetailsNCT05300477
Hypobaric Hypoxia
Natick, Massachusetts, United States
View Trial Details